世界の甲状腺診断・検査装置市場:医療機器パイプライン分析2016

◆英語タイトル:Thyroid Diagnostic Test - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0219EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年8月6日
◆ページ数:81
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥912,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,368,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、甲状腺診断・検査装置のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・甲状腺診断・検査装置の概要
・甲状腺診断・検査装置の開発動向:開発段階別分析
・甲状腺診断・検査装置の開発動向:セグメント別分析
・甲状腺診断・検査装置の開発動向:領域別分析
・甲状腺診断・検査装置の開発動向:規制Path別分析
・甲状腺診断・検査装置の開発動向:承認日(推定)別分析
・企業別甲状腺診断・検査装置の開発動向(パイプライン製品、進行中の治験)
・甲状腺診断・検査装置の最近動向
【レポートの概要】

Thyroid Diagnostic Test – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “Thyroid Diagnostic Test – Medical Devices Pipeline Assessment, 2016″ provides an overview of Thyroid Diagnostic Test currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Thyroid Diagnostic Test pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Thyroid Diagnostic Test under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Thyroid Diagnostic Test and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Thyroid Diagnostic Test under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Thyroid Diagnostic Test Overview 6
3 Products under Development 7
3.1 Thyroid Diagnostic Test – Pipeline Products by Stage of Development 7
3.2 Thyroid Diagnostic Test – Pipeline Products by Segment 8
3.3 Thyroid Diagnostic Test – Pipeline Products by Territory 9
3.4 Thyroid Diagnostic Test – Pipeline Products by Regulatory Path 10
3.5 Thyroid Diagnostic Test – Pipeline Products by Estimated Approval Date 11
4 Thyroid Diagnostic Test – Pipeline Products under Development by Companies 12
4.1 Thyroid Diagnostic Test Companies – Pipeline Products by Stage of Development 12
4.2 Thyroid Diagnostic Test – Pipeline Products by Stage of Development 13
5 Thyroid Diagnostic Test Companies and Product Overview 14
5.1 Achira Labs Pvt. Ltd. Company Overview 14
5.1.1 Achira Labs Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 AXO Science S.A.S. Company Overview 15
5.2.1 AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 DIESSE Diagnostica Senese S.p.A. Company Overview 16
5.3.1 DIESSE Diagnostica Senese S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 GeneFluidics Inc. Company Overview 17
5.4.1 GeneFluidics Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
5.5 Immunodiagnostic Systems Holdings plc Company Overview 21
5.5.1 Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview 21
5.6 MedMira Inc. Company Overview 23
5.6.1 MedMira Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.7 Mindray Medical International Limited Company Overview 25
5.7.1 Mindray Medical International Limited Pipeline Products & Ongoing Clinical Trials Overview 25
5.8 Novartis AG Company Overview 28
5.8.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 28
5.9 Ortho-Clinical Diagnostics Inc. Company Overview 30
5.9.1 Ortho-Clinical Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.10 Protagen AG Company Overview 31
5.10.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 31
5.11 Siemens Healthcare GmbH Company Overview 32
5.11.1 Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 32
5.12 Toshiba Medical Systems Corporation Company Overview 38
5.12.1 Toshiba Medical Systems Corporation Pipeline Products & Ongoing Clinical Trials Overview 38
5.13 True Diagnostics, Inc. Company Overview 39
5.13.1 True Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
5.14 University Rovira i Virgili Company Overview 41
5.14.1 University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 41
6 Thyroid Diagnostic Test – Recent Developments 42
6.1 Aug 04, 2016: PerkinElmer Announces Financial Results for the Second Quarter of 2016 42
6.2 Aug 03, 2016: Veracyte Announces Second Quarter 2016 Financial Results 42
6.3 Aug 01, 2016: Thermo Fisher Scientific Expands Offering for Clinical Applications at AACC 2016 43
6.4 Aug 01, 2016: Thermo Fisher Scientific Receives FDA Clearance for EliA Anti-Thyroglobulin and Anti-Thyroid Peroxidase Tests for Autoimmune Thyroid Disease 44
6.5 Jul 28, 2016: Thermo Fisher Scientific Reports Second Quarter 2016 Results 44
6.6 Jul 27, 2016: PerkinElmer Elects Frank Witney to Board of Directors 46
6.7 Jul 25, 2016: Ortho Clinical Diagnostics to Present Seven Scientific Posters, Six Products at AACC 46
6.8 Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results 48
6.9 Jul 20, 2016: Protagen Appoints Bernhard Kirschbaum as New Chairman and Oliver Schacht as New Board Member 50
6.10 Jul 19, 2016: Novartis delivered solid Q2 despite full quarter of US Gleevec generic impact; significant positive innovation news strengthens future growth prospects 51
6.11 Jul 18, 2016: bioMerieux – Second-Quarter 2016 Business Review 57
6.12 Jul 12, 2016: PerkinElmer Raises USD552.3 Million in Public Offering of 1.875% Senior Notes Due 2026 60
6.13 Jun 29, 2016: MedMira Reports FY2016 Third Quarter Results 60
6.14 Jun 22, 2016: Immunodiagnostic Systems Holdings Announces Financial Results 61
6.15 Jun 20, 2016: NOWDiagnostics Raises USD11 Million in Venture Financing 63
6.16 Jun 15, 2016: Siemens Healthcare Becomes Siemens Healthineers 63
6.17 Jun 13, 2016: Veracyte Announces Resignation of Its Chief Financial Officer 63
6.18 Jun 09, 2016: Immunodiagnostic Systems Holdings provides update on re royalty revenues 64
6.19 May 25, 2016: Novartis highlights its strong foundation for long-term, sustainable growth at the third Meet Novartis Management event 64
6.20 May 24, 2016: COTA Increases Cross-Industry Support With the Addition of Celgene, Foundation Medicine HealthScape Advisors and Novartis as Strategic Investors 65
6.21 May 18, 2016: Orphee to Raise USD2.6 Million in Private Placement of Shares 66
6.22 May 17, 2016: Novartis focuses Pharmaceuticals Division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology; appoints leaders to the Executive Committee of Novartis 66
6.23 May 16, 2016: Thermo Fisher Scientific Receives FDA Clearance for EliA Anti-Thyroglobulin and Anti-Thyroid Peroxidase Tests for Autoimmune Thyroid Disease 67
6.24 May 10, 2016: Thermo Fisher Scientific Reports Progress on Global Corporate Social Responsibility 67
6.25 May 05, 2016: Veracyte Announces First Quarter 2016 Financial Results 68
6.26 Apr 08, 2016: FDA Clears Siemens’ New Differential Graves’ Disease Assay 68
6.27 Mar 10, 2016: Veracyte Announces Fourth Quarter and Full-Year 2015 Financial Results, Provides 2016 Financial Outlook 69
6.28 Nov 11, 2015: DiaSorin Group reports growth in revenues and profitability in the third quarter 2015 and raises guidance on revenues and Ebitda for 2015 70
6.29 Nov 05, 2015: Medifast Announces Third Quarter 2015 Financial Results 75
6.30 Nov 04, 2015: Theraclion Partners with Burgerhospital Frankfurt 76
6.31 Aug 17, 2015: Veracyte Appoints Dr. Neil M. Barth as Chief Medical Officer 76
6.32 Aug 13, 2015: Veracyte Announces Second Quarter 2015 Financial Results 76
7 Appendix 78
7.1 Methodology 78
7.2 About GlobalData 80
7.3 Contact Us 80
7.4 Disclaimer 81

1.1 List of Tables
Table 1: Thyroid Diagnostic Test - Pipeline Products by Stage of Development 7
Table 2: Thyroid Diagnostic Test - Pipeline Products by Segment 8
Table 3: Thyroid Diagnostic Test - Pipeline Products by Territory 9
Table 4: Thyroid Diagnostic Test - Pipeline Products by Regulatory Path 10
Table 5: Thyroid Diagnostic Test - Pipeline Products by Estimated Approval Date 11
Table 6: Thyroid Diagnostic Test Companies - Pipeline Products by Stage of Development 12
Table 7: Thyroid Diagnostic Test - Pipeline Products by Stage of Development 13
Table 8: Achira Labs Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 14
Table 9: TSH Diagnostic Panel - Product Status 14
Table 10: TSH Diagnostic Panel - Product Description 14
Table 11: AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview 15
Table 12: Multiplexed Detection - TSH - Product Status 15
Table 13: Multiplexed Detection - TSH - Product Description 15
Table 14: DIESSE Diagnostica Senese S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 16
Table 15: Screening Kit - Autoimmune Thyroiditis - Product Status 16
Table 16: Screening Kit - Autoimmune Thyroiditis - Product Description 16
Table 17: GeneFluidics Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
Table 18: Free T3 Assay - Product Status 17
Table 19: Free T3 Assay - Product Description 18
Table 20: Free T4 Assay - Product Status 18
Table 21: Free T4 Assay - Product Description 18
Table 22: T3 Assay - Product Status 19
Table 23: T3 Assay - Product Description 19
Table 24: T4 Assay - Product Status 19
Table 25: T4 Assay - Product Description 20
Table 26: Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview 21
Table 27: IDS-iSYS Bioactive PTH (1-84) Kit - Product Status 21
Table 28: IDS-iSYS Bioactive PTH (1-84) Kit - Product Description 22
Table 29: MedMira Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 30: Reveal TSH Single Test - Product Status 23
Table 31: Reveal TSH Single Test - Product Description 24
Table 32: Mindray Medical International Limited Pipeline Products & Ongoing Clinical Trials Overview 25
Table 33: CL-2000i - Anti-TG Test - Product Status 25
Table 34: CL-2000i - Anti-TG Test - Product Description 25
Table 35: CL-2000i - Anti-TPO - Product Status 26
Table 36: CL-2000i - Anti-TPO - Product Description 26
Table 37: CL-2000i - Thyroglobulin (TG) Test - Product Status 26
Table 38: CL-2000i - Thyroglobulin (TG) Test - Product Description 27
Table 39: Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 28
Table 40: Diagnostic Test - Thyroid Stimulating Hormone - Product Status 28
Table 41: Diagnostic Test - Thyroid Stimulating Hormone - Product Description 29
Table 42: Ortho-Clinical Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
Table 43: Diagnostic Assay - Thyroid Diseases - Product Status 30
Table 44: Diagnostic Assay - Thyroid Diseases - Product Description 30
Table 45: Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 31
Table 46: Diagnostic Assay - Thyroid Disease - Product Status 31
Table 47: Diagnostic Assay - Thyroid Disease - Product Description 31
Table 48: Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 32
Table 49: ADVIA Centaur XPT Immunoassay System - Tg Assay - Product Status 32
Table 50: ADVIA Centaur XPT Immunoassay System - Tg Assay - Product Description 33
Table 51: Dimension Vista 1000T Intelligent Lab System - Intact PTH Assay - Product Status 33
Table 52: Dimension Vista 1000T Intelligent Lab System - Intact PTH Assay - Product Description 33
Table 53: Dimension Vista 1500 Intelligent Lab System - Intact PTH Assay - Product Status 34
Table 54: Dimension Vista 1500 Intelligent Lab System - Intact PTH Assay - Product Description 34
Table 55: Dimension Vista 3000T Intelligent Lab System - Intact PTH Assay - Product Status 34
Table 56: Dimension Vista 3000T Intelligent Lab System - Intact PTH Assay - Product Description 35
Table 57: Dimension Vista 500 Intelligent Lab System - Intact PTH Assay - Product Status 35
Table 58: Dimension Vista 500 Intelligent Lab System - Intact PTH Assay - Product Description 35
Table 59: IMMULITE 1000 Immunoassay System - TSI Assay - Product Status 36
Table 60: IMMULITE 1000 Immunoassay System - TSI Assay - Product Description 36
Table 61: IMMULITE 2000 Immunoassay System - TSI Assay - Product Status 36
Table 62: IMMULITE 2000 Immunoassay System - TSI Assay - Product Description 37
Table 63: Toshiba Medical Systems Corporation Pipeline Products & Ongoing Clinical Trials Overview 38
Table 64: Diagnostic Test - Thyroid Disorders - Product Status 38
Table 65: Diagnostic Test - Thyroid Disorders - Product Description 38
Table 66: True Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
Table 67: TrueDX - Thyroid Health - Product Status 39
Table 68: TrueDX - Thyroid Health - Product Description 39
Table 69: TrueDX - TSH Test - Product Status 40
Table 70: TrueDX - TSH Test - Product Description 40
Table 71: University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 41
Table 72: CD-Medics Test - Thyroiditis - Product Status 41
Table 73: CD-Medics Test - Thyroiditis - Product Description 41
Table 74: Glossary 79

1.2 List of Figures
Figure 1: Thyroid Diagnostic Test - Pipeline Products by Stage of Development 7
Figure 2: Thyroid Diagnostic Test - Pipeline Products by Segment 8
Figure 3: Thyroid Diagnostic Test - Pipeline Products by Territory 9
Figure 4: Thyroid Diagnostic Test - Pipeline Products by Regulatory Path 10
Figure 5: Thyroid Diagnostic Test - Pipeline Products by Estimated Approval Date 11

【掲載企業】

Achira Labs Pvt. Ltd.
AXO Science S.A.S.
DIESSE Diagnostica Senese S.p.A.
GeneFluidics Inc.
Immunodiagnostic Systems Holdings plc
MedMira Inc.
Mindray Medical International Limited
Novartis AG
Ortho-Clinical Diagnostics Inc.
Protagen AG
Siemens Healthcare GmbH
Toshiba Medical Systems Corporation
True Diagnostics, Inc.
University Rovira i Virgili

【レポートのキーワード】

甲状腺診断・検査装置

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[世界の甲状腺診断・検査装置市場:医療機器パイプライン分析2016]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月05日現在 219,162 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆